AbbVie Inc. (ABBV) vs GE Aerospace (GE)

AbbVie Inc. is a pharmaceutical company with significant exposure to immunology through Humira, Skyrizi, and Rinvoq, and to oncology through Imbruvica and Venclexta. The company was spun off from Abbott in early 2013. Its 2020 acquisition of Allergan expanded its portfolio with additional products in aesthetics, including Botox. In 2024, AbbVie further strengthened its business through the acquisitions of Cerevel in neuroscience and ImmunoGen in oncology.

GE Aerospace (GE) is a global leader in the design, manufacturing, and servicing of commercial aircraft turbine engines, including through its CFM joint venture with Safran. Supported by a vast installed base of nearly 80,000 commercial and military engines worldwide, the company generates most of its profits from recurring service revenue tied to equipment that remains in operation for decades. GE Aerospace is now the core remaining business of the company founded in 1892, which has historical connections to American inventor Thomas Edison. General Electric evolved into a renowned conglomerate, reaching peak revenue of $130 billion in 2000, before spinning off its appliance, finance, healthcare, wind, and power businesses between 2016 and 2024.